HomeClinical TopicsFDA authorizes use of Ebola test

FDA authorizes use of Ebola test

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize use of the LightMix® Ebola Zaire rRT-PCR Test for the presumptive detection of the Ebola Zaire virus in a preparation of whole blood from individuals with signs and symptoms of Ebola disease. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content